Thierry Guyon
Inventor
Stats
- 14 US patents issued
- 27 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 27 US Applications Filed
- 408 Total Citation Count
- Nov 14, 2012 Most Recent Filing
- Sep 8, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CATALYST BIOSCIENCES, INC. | 2
1 | 2007
2012 |
| Creabilis Therapeutics S.p.A. | 2
2 | 2007
2009 |
| HANALL BIOPHARMA CO., LTD. | 2
3 2 7 6 2 4 | 2003
2005 2006 2007 2008 2009 2011 |
| NAUTILUS BIOTECH S.A. | 2
| 2007
|
| AVENTIS PHARMA S.A. | 1
| 2007
|
| HANALL PHARMACEUTICAL CO., LTD. | 1
1 1 5 | 2003
2005 2006 2007 |
Inventor Addresses
| Address | Duration |
|---|---|
| Palaiseau, FR | Jul 08, 04 - Sep 19, 13 |
| Vigneux sur Seine, FR | Jun 26, 08 - Jun 26, 08 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 5 |
| A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2013/0243,855 | 2013 | Modified coagulation factor IX polypeptides and use thereof for treatment | 9 |
| 8383388 | 2013 | Modified coagulation factor IX polypeptides and use thereof for treatment | 18 |
| 2012/0264,686 | 2012 | MODIFIED ERYTHROPOIETIN (EPO) POLYPEPTIDES THAT EXHIBIT INCREASED PROTEASE RESISTANCE AND PHARMACEUTICAL COMPOSITIONS THEREOF | 9 |
| 8252743 | 2012 | Modified erythropoietin polypeptides and uses thereof for treatment | 7 |
| 8222209 | 2012 | Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof | 11 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.